Stockreport

Acura Pharmaceuticals Engages Catalent Pharma Solutions to Advance Development of LTX-03

ACURA PHARMS INC  (ACUR) 
Last acura pharms inc earnings: 8/14 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.acurapharm.com/investor-relations
PDF PALATINE, Ill., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC Pink: ACUR), today announced that it has engaged Catalent Pharma Solutions, LLC (“C [Read more]